Prevalence of adiposity-based chronic disease and its association with anthropometric and clinical indices. A cross-sectional study Academic Article in Scopus uri icon

abstract

  • © The Authors 2022.The present study aimed to determine the prevalence of adiposity-based chronic disease (ABCD) and its association with anthropometric indices in the Mexican population. A cross-sectional study was conducted in 514 adults seen at a clinical research unit. The American Association of Clinical Endocrinology/AACE/ACE criteria were used to diagnose ABCD by first identifying subjects with BMI¿25 kg/m2 and those with BMI of 23-24.9 kg/m2 and waist circumference¿80 cm in women or¿90 cm in men. The presence of metabolic and clinical complications associated with adiposity, such as factors related to metabolic syndrome, prediabetes, type 2 diabetes, dyslipidaemia, and arterial hypertension, were subsequently evaluated. Anthropometric indices related to cardiometabolic risk factors were then determined. The results showed the prevalence of ABCD was 87.4% in total, 91.5% in men, and 86% in women. The prevalence of ABCD stage 0 was 2.4%, stage 1 was 33.7%, and stage 2 was 51.3%. The prevalence of obesity according to BMI was 57.6%. The waist/hip circumference index (prevalence ratio (PR)=7.57; 95% CI 1.52-37.5) and the conicity index (PR=3.46; 95% CI 1.34-8.93) were better predictors of ABCD, while appendicular skeletal mass % and skeletal muscle mass % decreased the risk of developing ABCD (PR=0.93; 95% CI 0.90-0.96; and PR=0.95; 95% CI 0.93-0.98). Conclusion, the prevalence of ABCD in our study was 87.4%. This prevalence increased with age. It is important to emphasise that one out of two subjects had severe obesity-related complications (ABCD stage 2).

publication date

  • July 14, 2023